Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
International Archives of Occupational and Environmental Health
|
September 26, 2019
Relationships between recovery experiences and well-being among younger and older teachers
Anniina Virtanen, Jessica De Bloom, Ulla Kinnunen
SLAS Discovery : Advancing Life Sciences R & D
|
May 6, 2023
Development of an enzyme-coupled activity assay for Janus kinase 2 inhibitor screening
Angelika Pölläniemi, Anniina Virtanen, Olli Silvennoinen, et al.
Stress and Health : Journal of the International Society for the Investigation of Stress
|
March 5, 2021
Drammatic breaks: Break recovery experiences as mediators between job demands and affect in the afternoon and evening
Anniina Virtanen, Michelle Van Laethem, Jessica de Bloom, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 3, 2023
Differences in JAK Isoform Selectivity Among Different Types of JAK Inhibitors Evaluated for Rheumatic Diseases Through In Vitro Profiling
Anniina Virtanen, Maaria Palmroth, Sanna Liukkonen, et al.
Advances in Biological Regulation
|
January 4, 2025
Molecular basis of JAK kinase regulation guiding therapeutic approaches: Evaluating the JAK3 pseudokinase domain as a drug target
Anniina Virtanen, Vivian Kettunen, Kirsikka Musta, et al.
Nature Reviews. Rheumatology
|
September 9, 2024
JAK inhibitor selectivity: new opportunities, better drugs?
Anniina Virtanen, Francesca Romana Spinelli, Jean Baptiste Telliez, et al.
Journal of Medicinal Chemistry
|
June 6, 2024
Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity
Ya Miao, Anniina Virtanen, Jakub Zmajkovic, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
<i>IRF2BP2</i> Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia
Maaria Palmroth, Hanna Viskari, Mikko R J Seppänen, et al.
Frontiers in Immunology
|
October 11, 2021
Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis <i>In Vivo</i> and Baseline Signaling Profile Associates With Treatment Response
Maaria Palmroth, Krista Kuuliala, Ritva Peltomaa, et al.
Clinical and Experimental Immunology
|
September 20, 2022
Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response
Atte Valli, Krista Kuuliala, Anniina Virtanen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
International Archives of Occupational and Environmental Health
|
September 26, 2019
Relationships between recovery experiences and well-being among younger and older teachers
Anniina Virtanen, Jessica De Bloom, Ulla Kinnunen
SLAS Discovery : Advancing Life Sciences R & D
|
May 6, 2023
Development of an enzyme-coupled activity assay for Janus kinase 2 inhibitor screening
Angelika Pölläniemi, Anniina Virtanen, Olli Silvennoinen, et al.
Stress and Health : Journal of the International Society for the Investigation of Stress
|
March 5, 2021
Drammatic breaks: Break recovery experiences as mediators between job demands and affect in the afternoon and evening
Anniina Virtanen, Michelle Van Laethem, Jessica de Bloom, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 3, 2023
Differences in JAK Isoform Selectivity Among Different Types of JAK Inhibitors Evaluated for Rheumatic Diseases Through In Vitro Profiling
Anniina Virtanen, Maaria Palmroth, Sanna Liukkonen, et al.
Advances in Biological Regulation
|
January 4, 2025
Molecular basis of JAK kinase regulation guiding therapeutic approaches: Evaluating the JAK3 pseudokinase domain as a drug target
Anniina Virtanen, Vivian Kettunen, Kirsikka Musta, et al.
Nature Reviews. Rheumatology
|
September 9, 2024
JAK inhibitor selectivity: new opportunities, better drugs?
Anniina Virtanen, Francesca Romana Spinelli, Jean Baptiste Telliez, et al.
Journal of Medicinal Chemistry
|
June 6, 2024
Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity
Ya Miao, Anniina Virtanen, Jakub Zmajkovic, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
<i>IRF2BP2</i> Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia
Maaria Palmroth, Hanna Viskari, Mikko R J Seppänen, et al.
Frontiers in Immunology
|
October 11, 2021
Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis <i>In Vivo</i> and Baseline Signaling Profile Associates With Treatment Response
Maaria Palmroth, Krista Kuuliala, Ritva Peltomaa, et al.
Clinical and Experimental Immunology
|
September 20, 2022
Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response
Atte Valli, Krista Kuuliala, Anniina Virtanen, et al.
Page
of 1